Skip to content
PubMed This is a summary of 18 peer-reviewed journal articles Updated
Endocrinology

What Does an SRY-Negative 46,XX Testicular DSD Mean?

At a Glance

SRY-negative 46,XX testicular DSD means the SRY gene was not detected by the test, but testicular tissue developed despite an XX chromosome pattern. Other genetic changes can be involved, and additional testing plus specialist care can clarify hormone needs, fertility options, and next steps.

When genetic test results for 46,XX testicular difference of sex development (DSD) come back as SRY-negative, it means the SRY gene was not detected by the specific test used [1].

To break this down:

  • 46,XX is the chromosome pattern typically associated with female development.
  • Testicular DSD means that testicular tissue developed despite this chromosome pattern.
  • SRY-negative means that the standard genetic “master switch” for testicular development (the SRY gene, normally found on the Y chromosome) was not found in the tested sample.

In about 80% of individuals with 46,XX testicular DSD, the SRY gene is present because a piece of the Y chromosome containing it has attached (translocated) to another chromosome [2]. However, studies estimate that about 20% of cases are SRY-negative [2]. In these instances, testicular tissue still formed, triggered by a different genetic variation—though the specific cause may remain unknown [1][3].

How Does Testicular Tissue Develop Without the SRY Gene?

Fetal sex development relies on a complex balance between a pathway that promotes testicular development and a pathway that promotes ovarian development [4]. If the SRY gene is missing, testicular tissue can still form if this balance shifts due to other genetic changes [4]. This can happen in several ways, though for many patients, the exact genetic cause is never found [3]. Known mechanisms include:

  • Overactive Pro-Testis Genes: Other genes that promote male development may have extra copies (known as duplications). Well-established examples include the SOX9 and SOX3 genes. If regulatory regions for these genes are duplicated, they can independently trigger the body to form testicular tissue [5][6].
  • Disrupted Pro-Ovarian Genes: Genes that normally promote ovarian development, such as RSPO1 or WNT4, may not function correctly. For example, specific mutations in RSPO1 are a rare cause of 46,XX testicular development and can also be associated with skin conditions like palmoplantar hyperkeratosis [7][8].
  • Other Rare Variants: Specific variations in several other genes, including WT1 and NR5A1, have occasionally been linked to 46,XX testicular development in rare cases, though these do not always produce the same physical outcome [9].

How is SRY-Negative Different from SRY-Positive?

Knowing whether a patient is SRY-negative or SRY-positive is important because the two types tend to present differently, though these are general trends, not absolute rules:

  • Time of Diagnosis: Because SRY-negative cases often involve more noticeable differences in genital development, they are frequently diagnosed during infancy [10][11]. For example, in one specific study cohort, 75% of SRY-negative patients were diagnosed in the neonatal period [11]. By contrast, SRY-positive individuals typically have typical male external genitalia and are often not diagnosed until adulthood during evaluations for infertility [12].
  • Physical Characteristics: SRY-negative children tend to have more variable or atypical genital development (differences in genital appearance) compared to SRY-positive children [10]. However, some SRY-negative individuals are born with a typical male appearance and are diagnosed later in life [11].

What This Result Does Not Tell You

An SRY-negative result provides genetic context, but it does not dictate everything about a person’s life or body:

  • Gender Identity: A genetic description of sex development does not determine a person’s gender identity, gender expression, or future identity.
  • Hormone Function: SRY status alone cannot predict whether the body will produce enough testosterone for puberty. This depends on the specific amount and function of the testicular tissue present [13].
  • Fertility Limits: Regardless of SRY status, the absence of a complete Y chromosome generally means that the capacity to produce sperm is severely limited or absent, so biological fertility usually requires specialized assisted reproductive technologies like donor sperm [13].

Next Steps and Care

A single negative SRY test is often just the beginning of the evaluation.

  • Advanced Genetic Testing: Standard tests might miss the cause. Your doctor may recommend a microarray (which looks for extra or missing pieces of DNA, like SOX9 duplications) or exome sequencing (which looks closely at the spelling of specific genes) [14][15]. Because no single test catches everything, testing should be guided by a geneticist based on your specific clinical findings [16].
  • Individualized, Multidisciplinary Care: Because SRY-negative 46,XX testicular DSD is complex and affects individuals differently, care is best managed by a specialized DSD team [17]. This team includes endocrinologists to monitor hormone function and puberty, urologists, geneticists, and psychosocial professionals who support informed, shared decision-making regarding any treatments or monitoring [17][18].

Common questions in this guide

What does an SRY-negative result mean in 46,XX testicular DSD?
It means the SRY gene was not detected by the specific test used. The person has an XX chromosome pattern and testicular tissue developed, so the result describes one part of sex development rather than the whole picture.
How can testicular tissue develop if SRY is not detected?
Other genetic changes can shift the balance of fetal sex development toward testicular tissue. Examples include extra copies or regulatory changes affecting SOX9 or SOX3 and changes in RSPO1 or WNT4, but the cause is not found in many people.
Does an SRY-negative result predict puberty, hormones, or gender identity?
No. SRY status alone cannot predict how much testosterone the gonadal tissue will produce or how puberty will progress, and a genetic description of sex development does not determine gender identity or expression. Individual assessment of gonadal tissue and hormone function is needed.
What testing may be recommended after a negative SRY test?
A geneticist may recommend a chromosomal microarray to look for extra or missing DNA segments and exome sequencing to examine many genes in detail. The best testing depends on the person’s clinical findings, and no single test detects every possible cause.
How might SRY-negative 46,XX testicular DSD affect fertility?
Because a complete Y chromosome is generally absent, sperm production is usually severely limited or absent. Fertility planning may involve specialized assisted reproductive technologies, such as donor sperm, and should be discussed with an appropriate specialist.
When is SRY-negative 46,XX testicular DSD usually diagnosed?
Many SRY-negative cases are identified in infancy because genital development may look different, but some people have typical male external genitalia and are diagnosed later. Later evaluation may occur during infertility assessment.
What specialists should be involved in care?
A multidisciplinary DSD team may include an endocrinologist, urologist, geneticist, and psychosocial professional. The team can coordinate evaluation of hormones, anatomy, genetic findings, fertility, and decisions about monitoring or treatment.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Given this SRY-negative result, which advanced genetic tests (such as a microarray or sequencing) are most appropriate for finding the underlying cause?
  2. 2.What specific tissue is present in the gonads, and what hormone tests or imaging do we need to track their function right now?
  3. 3.What does this specific genetic result and my current anatomy mean for future puberty, fertility options, or the need for gonadal surveillance?
  4. 4.Can you connect us with a multidisciplinary DSD specialist team and reputable peer support resources?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (18)
  1. 1

    Testicular XX (SRY-Negative) Disorder of Sex Development in Cat.

    De Lorenzi L, Banco B, Previderè C, et al.

    Sexual development : genetics, molecular biology, evolution, endocrinology, embryology, and pathology of sex determination and differentiation 2017; (11(4)):210-216 doi:10.1159/000479175.

    PMID: 28848109
  2. 2

    Male patient 46,XX SRY-negative and unambiguous genitalia: A case report

    Casas-Vargas A, Galvis J, Blanco J, et al.

    Biomedica : revista del Instituto Nacional de Salud 2019; (39(4)):622-630 doi:10.7705/biomedica.4687.

    PMID: 31860174
  3. 3

    Testicular differentiation in 46,XX DSD: an overview of genetic causes.

    Ferrari MTM, Silva ESDN, Nishi MY, et al.

    Frontiers in endocrinology 2024; (15()):1385901 doi:10.3389/fendo.2024.1385901.

    PMID: 38721146
  4. 4

    Disorders of Sex Development with Testicular Differentiation in SRY-Negative 46,XX Individuals: Clinical and Genetic Aspects.

    Grinspon RP, Rey RA

    Sexual development : genetics, molecular biology, evolution, endocrinology, embryology, and pathology of sex determination and differentiation 2016; (10(1)):1-11 doi:10.1159/000445088.

    PMID: 27055195
  5. 5

    Copy number variation of two separate regulatory regions upstream of SOX9 causes isolated 46,XY or 46,XX disorder of sex development.

    Kim GJ, Sock E, Buchberger A, et al.

    Journal of medical genetics 2015; (52(4)):240-7 doi:10.1136/jmedgenet-2014-102864.

    PMID: 25604083
  6. 6

    Interchromosomal insertional translocation at Xq26.3 alters SOX3 expression in an individual with XX male sex reversal.

    Haines B, Hughes J, Corbett M, et al.

    The Journal of clinical endocrinology and metabolism 2015; (100(5)):E815-20 doi:10.1210/jc.2014-4383.

    PMID: 25781358
  7. 7

    Novel RSPO1 mutation causing 46,XX testicular disorder of sex development with palmoplantar keratoderma: A review of literature and expansion of clinical phenotype.

    Tallapaka K, Venugopal V, Dalal A, Aggarwal S

    American journal of medical genetics. Part A 2018; (176(4)):1006-1010 doi:10.1002/ajmg.a.38646.

    PMID: 29575617
  8. 8

    Diagnosis and management of non-CAH 46,XX disorders/differences in sex development.

    Yavas Abalı Z, Guran T

    Frontiers in endocrinology 2024; (15()):1354759 doi:10.3389/fendo.2024.1354759.

    PMID: 38812815
  9. 9

    Testis formation in XX individuals resulting from novel pathogenic variants in Wilms' tumor 1 (WT1) gene.

    Eozenou C, Gonen N, Touzon MS, et al.

    Proceedings of the National Academy of Sciences of the United States of America 2020; (117(24)):13680-13688 doi:10.1073/pnas.1921676117.

    PMID: 32493750
  10. 10

    [Genetic and clinical characteristics of 46,XX testicular disorders of sex development].

    Ye QL, Fang JZ, Yang XY

    Zhonghua nan ke xue = National journal of andrology 2024; (30(2)):118-122.

    PMID: 39177343
  11. 11

    SRY-negative 46,XX testicular/ovotesticular DSD: Long-term outcomes and early blockade of gonadotropic axis.

    Lambert S, Peycelon M, Samara-Boustani D, et al.

    Clinical endocrinology 2021; (94(4)):667-676 doi:10.1111/cen.14389.

    PMID: 33296530
  12. 12

    SRY-positive 46,XX testicular disorder of sex development in adult monozygotic twins.

    Pantović V, Tančić-Gajić M, Miletić M, et al.

    JCEM case reports 2026; (4(8)):luag180 doi:10.1210/jcemcr/luag180.

    PMID: 42445480
  13. 13

    Clinical and genetic analysis in males with 46,XX disorders of sex development: A reproductive centre experience of 144 cases.

    Chen T, Tian L, Wu F, et al.

    Andrologia 2019; (51(4)):e13232 doi:10.1111/and.13232.

    PMID: 30623467
  14. 14

    The smallest likely pathogenic duplication of a SOX9 enhancer identified to date in a family with 46,XX testicular differences of sex development.

    Sajan SA, Brown CM, Davis-Keppen L, et al.

    American journal of medical genetics. Part A 2023; (191(12)):2831-2836 doi:10.1002/ajmg.a.63367.

    PMID: 37551848
  15. 15

    Gonadal Genetics and Germ Cell Tumor Risk in SRY-Negative 46,XX Testicular/Ovotesticular Disorders of Sex Development.

    Yang H, Tian H, Wu D, et al.

    Hormone research in paediatrics 2025; 1-9 doi:10.1159/000548934.

    PMID: 41108712
  16. 16

    A rare case of 46, XX (SRY positive) testicular disorder of sex development with growth hormone deficiency: Case report.

    Li H, He J, Leong I

    Medicine 2021; (100(6)):e24641 doi:10.1097/MD.0000000000024641.

    PMID: 33578586
  17. 17

    Role of the pediatrician in the initial management of a newborn with Differences of Sex Development or hypospadias.

    van der Straaten S, Syryn H, Dessens A, et al.

    European journal of pediatrics 2025; (184(5)):307 doi:10.1007/s00431-025-06140-6.

    PMID: 40261419
  18. 18

    The laboratory in the multidisciplinary diagnosis of differences or disorders of sex development (DSD): I) Physiology, classification, approach, and methodologyII) Biochemical and genetic markers in 46,XX DSD.

    Granada ML, Audí L

    Advances in laboratory medicine 2021; (2(4)):468-493 doi:10.1515/almed-2021-0042.

    PMID: 37360895

This page is for informational purposes only and does not constitute medical advice. SRY-negative results should be interpreted with a DSD specialist team and genetic counselor, who can discuss an individual’s anatomy, hormones, fertility, and care.

Get notified when new evidence is published on 46,XX testicular difference of sex development.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.